Drug · DIN 02544679
BACLOFEN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since May 31, 2024; first marketed May 31, 2024.
- Drug Identification Number (DIN)
- 02544679
- Company (DIN owner)
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Baclofen M03BX01
- Class
- Human
- Record last updated
- March 22, 2025
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| BACLOFEN | 20 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- January 19, 2024: NOC 32572New Drug Submission (NDS) · Administrative: Licensing Agreement Between Two Manufacturers
Other DINs named BACLOFEN
- DIN 02287021 · Marketed
- DIN 02287048 · Marketed
- DIN 02544660 · Marketed
- DIN 02136090 · Cancelled Post Market
- DIN 02136104 · Cancelled Post Market